{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T04:20:26Z","timestamp":1790482826204,"version":"4.1.0"},"reference-count":36,"publisher":"Elsevier BV","issue":"25","license":[{"start":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T00:00:00Z","timestamp":1496275200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T00:00:00Z","timestamp":1496275200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,6,27]],"date-time":"2018-06-27T00:00:00Z","timestamp":1530057600000},"content-version":"vor","delay-in-days":391,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American College of Cardiology"],"published-print":{"date-parts":[[2017,6]]},"DOI":"10.1016\/j.jacc.2017.04.011","type":"journal-article","created":{"date-parts":[[2017,4,12]],"date-time":"2017-04-12T19:04:38Z","timestamp":1492023878000},"page":"3055-3066","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":108,"title":["Everolimus-Eluting Bioresorbable Scaffolds Versus Everolimus-Eluting Metallic Stents"],"prefix":"10.1016","volume":"69","author":[{"given":"Sabato","family":"Sorrentino","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gennaro","family":"Giustino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roxana","family":"Mehran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anapoorna S.","family":"Kini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samin K.","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michela","family":"Faggioni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serdar","family":"Farhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Birgit","family":"Vogel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ciro","family":"Indolfi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George D.","family":"Dangas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacc.2017.04.011_bib1","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1038\/nrcardio.2016.151","article-title":"Bioresorbable vascular scaffolds - basic concepts and clinical outcome","volume":"13","author":"Indolfi","year":"2016","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.jacc.2017.04.011_bib2","doi-asserted-by":"crossref","first-page":"2288","DOI":"10.1161\/CIRCULATIONAHA.109.921528","volume":"122","author":"Onuma","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2017.04.011_bib3","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1161\/CIRCIMAGING.114.001727","article-title":"Neointimal proliferation is associated with clinical restenosis 2 years after fully bioresorbable vascular scaffold implantation","volume":"7","author":"Indolfi","year":"2014","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1016\/j.jacc.2017.04.011_bib4","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1016\/j.jacc.2015.08.853","article-title":"Very late scaffold thrombosis: intracoronary imaging and histopathological and spectroscopic findings","volume":"66","author":"Raber","year":"2015","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2017.04.011_bib5","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1056\/NEJMoa1509038","article-title":"Everolimus-eluting bioresorbable scaffolds for coronary artery disease","volume":"373","author":"Ellis","year":"2015","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2017.04.011_bib6","unstructured":"Ellis S, Kereiakes D, Stone G. Everolimus-eluting Bioresorbable vascular scaffolds in patients with coronary artery disease: ABSORB III Trial 2-Year Results. Presented at: Annual Meeting of the American College of Cardiology; March 18, 2017; Washington, DC."},{"key":"10.1016\/j.jacc.2017.04.011_bib7","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa1614954","article-title":"Bioresorbable scaffolds versus metallic stents in routine PCI","author":"Wykrzykowska","year":"2017","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2017.04.011_bib8","unstructured":"U.S. Food and Drug Administration. Absorb GT1 Bioresorbable Vascular Scaffold (BVS) by Abbott Vascular: Letter to Health Care Providers - FDA Investigating Increased Rate of Major Adverse Cardiac Events. March 18, 2017. Available at: https:\/\/www.fda.gov\/Safety\/MedWatch\/SafetyInformation\/SafetyAlertsforHumanMedicalProducts\/ucm547256.htm. Accessed April 26,\u00a02017."},{"key":"10.1016\/j.jacc.2017.04.011_bib9","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.ijsu.2010.02.007","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"8","author":"Moher","year":"2010","journal-title":"Int J Surg"},{"key":"10.1016\/j.jacc.2017.04.011_bib10","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/j.amjcard.2008.04.050","article-title":"Incidence of coronary stent thrombosis based on academic research consortium definitions","volume":"102","author":"Applegate","year":"2008","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2017.04.011_bib11","doi-asserted-by":"crossref","first-page":"d5928","DOI":"10.1136\/bmj.d5928","article-title":"The Cochrane Collaboration's tool for assessing risk of bias in randomised trials","volume":"343","author":"Higgins","year":"2011","journal-title":"BMJ"},{"key":"10.1016\/j.jacc.2017.04.011_bib12","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"10.1016\/j.jacc.2017.04.011_bib13","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1136\/bmj.323.7304.101","article-title":"Systematic reviews in health care: investigating and dealing with publication and other biases in meta-analysis","volume":"323","author":"Sterne","year":"2001","journal-title":"BMJ"},{"key":"10.1016\/j.jacc.2017.04.011_bib14","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1471-2288-2-2","article-title":"Pooling data for number needed to treat: no problems for apples","volume":"2","author":"Moore","year":"2002","journal-title":"BMC Med Res Methodol"},{"key":"10.1016\/j.jacc.2017.04.011_bib15","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/S0140-6736(10)60903-8","article-title":"An international registry of systematic-review protocols","volume":"377","author":"Booth","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2017.04.011_bib16","unstructured":"Puricel S. Comparison of everolimus and biolimus-eluting coronary stents with everolimus-eluting bioresorbable vascular scaffolds: 2-year outcomes of the EVERBIO II Trial. Presented at: Annual TCT Conference; October 14, 2015; San Francisco, California. Available at: https:\/\/www.tctmd.com\/slide\/new-randomized-trial-data-2-year-outcomes-everbio-ii. Accessed April 26,\u00a02017."},{"key":"10.1016\/j.jacc.2017.04.011_bib17","unstructured":"Gao R. ABSORB-China: two-year clinical in patients with coronary artery disease randomized to the Absorb bioresorbable vascular scaffold versus metallic drug-eluting stents. Paper presented at: TCT 2016; October 30, 2016; Washington, DC. Available at: https:\/\/www.tctmd.com\/slide\/absorb-china-two-year-clinical-outcomes-prospective-randomized-trial-everolimus-eluting. Accessed April 26,\u00a02017."},{"issue":"Suppl","key":"10.1016\/j.jacc.2017.04.011_bib18","doi-asserted-by":"crossref","first-page":"B20","DOI":"10.1016\/j.jacc.2016.09.194","volume":"68","author":"Windecker","year":"2016","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2017.04.011_bib19","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.4244\/EIJY16M09_01","article-title":"Two-year clinical, angiographic, and serial optical coherence tomographic follow-up after implantation of an everolimus-eluting bioresorbable scaffold and an everolimus-eluting metallic stent: insights from the randomised ABSORB Japan trial","volume":"12","author":"Onuma","year":"2016","journal-title":"EuroIntervention"},{"key":"10.1016\/j.jacc.2017.04.011_bib20","doi-asserted-by":"crossref","first-page":"2479","DOI":"10.1016\/S0140-6736(16)32050-5","article-title":"Comparison of an everolimus-eluting bioresorbable scaffold with an everolimus-eluting metallic stent for the treatment of coronary artery stenosis (ABSORB II): a 3 year, randomised, controlled, single-blind, multicentre clinical trial","volume":"388","author":"Serruys","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2017.04.011_bib21","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1016\/j.jcin.2016.03.038","article-title":"Stent thrombosis with drug-eluting stents and bioresorbable scaffolds: evidence from a network meta-analysis of 147 trials","volume":"9","author":"Kang","year":"2016","journal-title":"J\u00a0Am Coll Cardiol Intv"},{"key":"10.1016\/j.jacc.2017.04.011_bib22","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1016\/j.jcin.2013.05.005","volume":"6","author":"Dangas","year":"2013","journal-title":"J\u00a0Am Coll Cardiol Intv"},{"key":"10.1016\/j.jacc.2017.04.011_bib23","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1016\/j.jacc.2010.07.028","article-title":"In-stent restenosis in the drug-eluting stent era","volume":"56","author":"Dangas","year":"2010","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2017.04.011_bib24","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/j.amjcard.2015.06.010","volume":"116","author":"Giustino","year":"2015","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2017.04.011_bib25","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.jcin.2015.09.023","article-title":"Effect of chronic kidney disease in women undergoing percutaneous coronary intervention with drug-eluting stents: a patient-level pooled analysis of randomized controlled trials","volume":"9","author":"Baber","year":"2016","journal-title":"J\u00a0Am Coll Cardiol Intv"},{"key":"10.1016\/j.jacc.2017.04.011_bib26","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1016\/j.jcin.2015.12.013","article-title":"Safety and efficacy of new-generation drug-eluting stents in women undergoing complex percutaneous coronary artery revascularization: from the WIN-DES collaborative patient-level pooled analysis","volume":"9","author":"Giustino","year":"2016","journal-title":"J\u00a0Am Coll Cardiol Intv"},{"key":"10.1016\/j.jacc.2017.04.011_bib27","doi-asserted-by":"crossref","first-page":"e002995","DOI":"10.1161\/CIRCINTERVENTIONS.115.002995","article-title":"Safety and efficacy of new-generation drug-eluting stents in women at high risk for atherothrombosis: from the Women in Innovation and Drug-Eluting Stents Collaborative Patient-Level Pooled Analysis","volume":"9","author":"Giustino","year":"2016","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.jacc.2017.04.011_bib28","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1161\/CIRCULATIONAHA.116.021539","article-title":"Bioresorbable vascular scaffolds for coronary revascularization","volume":"134","author":"Kereiakes","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2017.04.011_bib29","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/S0140-6736(15)00979-4","article-title":"Everolimus-eluting bioresorbable vascular scaffolds versus everolimus-eluting metallic stents: a meta-analysis of randomised controlled trials","volume":"387","author":"Cassese","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2017.04.011_bib30","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.jcin.2016.10.027","article-title":"Very late scaffold thrombosis of bioresorbable vascular scaffold: systematic review and a meta-analysis","volume":"10","author":"Toyota","year":"2017","journal-title":"J\u00a0Am Coll Cardiol Intv"},{"key":"10.1016\/j.jacc.2017.04.011_bib31","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1016\/j.jcin.2015.03.029","article-title":"Acute thrombogenicity of a durable polymer everolimus-eluting stent relative to contemporary drug-eluting stents with biodegradable polymer coatings assessed ex\u00a0vivo in a swine shunt model","volume":"8","author":"Otsuka","year":"2015","journal-title":"J\u00a0Am Coll Cardiol Intv"},{"key":"10.1016\/j.jacc.2017.04.011_bib32","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0140-6736(14)61455-0","volume":"385","author":"Serruys","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2017.04.011_bib33","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1161\/01.CIR.91.6.1676","article-title":"Intracoronary stenting without anticoagulation accomplished with intravascular ultrasound guidance","volume":"91","author":"Colombo","year":"1995","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2017.04.011_bib34","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1186\/s12872-015-0163-5","article-title":"The duration of balloon inflation affects the luminal diameter of coronary segments after bioresorbable vascular scaffolds deployment","volume":"15","author":"Sorrentino","year":"2015","journal-title":"BMC Cardiovasc Disorders"},{"key":"10.1016\/j.jacc.2017.04.011_bib35","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.ijcard.2016.03.070","article-title":"Outcomes with bioabsorbable vascular scaffolds versus everolimus eluting stents: insights from randomized trials","volume":"212","author":"Bangalore","year":"2016","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jacc.2017.04.011_bib36","first-page":"32","article-title":"Early, late and very late incidence of bioresorbable scaffold thrombosis: a systematic review and meta-analysis of randomized clinical trials and observational studies","volume":"65","author":"Collet","year":"2017","journal-title":"Minerva Cardioangiol"}],"container-title":["Journal of the American College of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109717370134?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109717370134?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T13:12:57Z","timestamp":1760015577000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0735109717370134"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6]]},"references-count":36,"journal-issue":{"issue":"25","published-print":{"date-parts":[[2017,6]]}},"alternative-id":["S0735109717370134"],"URL":"https:\/\/doi.org\/10.1016\/j.jacc.2017.04.011","relation":{},"ISSN":["0735-1097"],"issn-type":[{"value":"0735-1097","type":"print"}],"subject":[],"published":{"date-parts":[[2017,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Everolimus-Eluting Bioresorbable Scaffolds Versus Everolimus-Eluting Metallic Stents","name":"articletitle","label":"Article Title"},{"value":"Journal of the American College of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacc.2017.04.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 by the American College of Cardiology Foundation. Published by Elsevier.","name":"copyright","label":"Copyright"}]}}